课题基金 / 基金详情

Exploring the use of exosomal plasma gelsolin as a biomarker for early ovarian cancer diagnosis

Exploring the use of exosomal plasma gelsolin as a biomarker for early ovarian cancer diagnosis
探索使用外泌体血浆凝溶胶蛋白作为早期卵巢癌诊断的生物标志物
批准号：
467118
负责人：
Gerber Emma
金额：
$1.27万
依托单位：
University of Ottawa
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-12-01 至 2022-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=467118&lang=en
关键词：
Biomarkers Chemoresistance Early Diagnosis Exosomes Figo Stage Histopathological Subtypes Ovarian Cancer Patient Survival Plasma Gelsolin Small Extracellular Vesicles

项目摘要

项目成果

Gerber Emma的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Ovarian cancer (OVCA) is the most lethal gynecological disease. Unfortunately, less than half of those diagnosed with OVCA will live to see the next 5 years. One of the reasons for this low survival rate is because OVCA is not usually diagnosed until adva
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Combination of plasma gelsolin with radiological imaging for prognostication of ovarian cancer
  • 批准号：
    495885
  • 项目类别：
    Miscellaneous Programs
  • 资助金额：
    $0.44万
  • 财政年份：
    2023
  • 负责人：
    Gerber Emma
  • 依托单位：
    University of Hong Kong
The relationship between disease progression and chemoresistance mediated by plasma gelsolin in epithelial ovarian cancer
  • 批准号：
    476288
  • 项目类别：
    Studentship Programs
  • 资助金额：
    $7.65万
  • 财政年份：
    2022
  • 负责人：
    Gerber Emma
  • 依托单位：
    Ottawa Hospital Research Institute
海外基金